Description

(3E,5E,9S,10S,12S,13S,14E,19S,20R)-4,19-Dimethyl-20-[(2R,3S)-3-[(1S)-1-methylbutyl]oxiranyl]-9,10,12,13-tetrahydroxy-8,11,17-tri(methylene)oxacycloicosa-3,5,14-triene-2-one is a complex, high-purity macrolide compound of significant interest in advanced pharmaceutical research and development. Its intricate stereochemistry and functional groups make it a valuable intermediate or reference standard for the synthesis of novel bioactive molecules. This compound is primarily utilized by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a key chiral building block in the synthesis of complex macrolide-based drug candidates.
• Reference Standard: Used in analytical method development and validation for quality control in pharmaceutical manufacturing.
• Biochemical Research: Employed in studies investigating structure-activity relationships (SAR) and biological pathways.
• Medicinal Chemistry: Acts as a core scaffold for the design and optimization of new chemical entities with potential therapeutic activity.
• Process Chemistry Development: Used in scaling up synthetic routes for the production of target molecules.

Basic Information

Product Name	(3E,5E,9S,10S,12S,13S,14E,19S,20R)-4,19-Dimethyl-20-[(2R,3S)-3-[(1S)-1-methylbutyl]oxiranyl]-9,10,12,13-tetrahydroxy-8,11,17-tri(methylene)oxacycloicosa-3,5,14-triene-2-one
CAS No.	106463-75-6
Molecular Formula	C31H46O8
Molecular Weight	546.70 g/mol
Synonyms	4,19-Dimethyl-20-[(2R,3S)-3-[(1S)-1-methylbutyl]oxiranyl]-9,10,12,13-tetrahydroxy-8,11,17-tri(methylene)oxacycloicosa-3,5,14-triene-2-one; (3E,5E,9S,10S,12S,13S,14E,19S,20R)-4,19-Dimethyl-20-[(2R,3S)-3-[(1S)-1-methylbutyl]oxiranyl]-9,10,12,13-tetrahydroxy-8,11,17-tri(methylene)oxacycloicosa-3,5,14-triene-2-one; Macrolide derivative CAS 106463-75-6; Complex oxacycloicosa polyol derivative
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards for research and pharmaceutical intermediates. We provide comprehensive analytical data including HPLC purity, chiral purity, and structural confirmation. Certificates of Analysis (COA) are available upon request, detailing batch-specific results. Our quality management system supports the needs of clients operating under GMP and ISO guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. Keep the container sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Chiral Purity (Chiral HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.